Crigler-Najjar syndrome is a rare inherited condition that causes very high bilirubin levels and ongoing jaundice. It is usually recognized in newborns or early infancy, and the early signs of Crigler-Najjar syndrome often include yellow skin and eyes soon after birth. Not everyone will have the same experience. More severe Crigler-Najjar syndrome can lead to brain injury and can be life-threatening without treatment, while milder forms may be managed into adulthood. Treatment often includes phototherapy, careful monitoring, and sometimes liver transplantation.
How many people live with Crigler-najjar syndrome?
Crigler-Najjar syndrome is so rare that exact counts are not available, but using Orphanet’s estimate that it affects fewer than 1 person in 1 million, fewer than about 8,000 people may be living with it worldwide (Orphanet, 2024). Using that same estimate, fewer than about 340 people may be living with it in the United States (Orphanet, 2024).
Overview
Crigler-najjar syndromeSymptoms
Crigler-Najjar syndrome mainly causes severe jaundice, meaning yellow skin and eyes, often starting soon after birth. In early signs of Crigler-Najjar syndrome, babies may seem very sleepy, feed poorly, or develop brain injury if bilirubin rises too high.
Outlook and prognosis
With Crigler-Najjar syndrome, outlook depends on the type: many with type 2 do well long term with treatment, while type 1 is more serious and usually needs intensive care, often including a liver transplant.
Causes and risk factors
Crigler-Najjar syndrome is caused by changes in the UGT1A1 gene, usually inherited from both parents. Family history raises risk, while other factors do not cause it but can affect how severe symptoms become.
Genetic influences
Genetics are central to Crigler-Najjar syndrome. It is usually caused by inherited changes in the UGT1A1 gene, and the exact variant often influences severity, which matters for family testing and genetic counseling.
Diagnosis
Crigler-Najjar syndrome is usually suspected from persistent jaundice starting early in life and very high unconjugated bilirubin levels on blood tests. Doctors also check liver function. The genetic diagnosis of Crigler-Najjar syndrome is confirmed with UGT1A1 genetic testing.
Treatment and drugs
Treatment for Crigler-Najjar syndrome aims to lower bilirubin and protect the brain. Depending on the type, this may include daily phototherapy, phenobarbital for type 2, and careful monitoring during illness. Some people with severe Crigler-Najjar syndrome may need a liver transplant.
Symptoms
Crigler-Najjar syndrome is usually noticed very early, often because yellowing of the skin and eyes is stronger or lasts longer than expected in a newborn. For many people with Crigler-Najjar syndrome, the early features of Crigler-Najjar syndrome are persistent jaundice and signs that too much bilirubin, a yellow pigment in the blood, is building up. Features can vary by type, with type I being more severe and type II often causing milder but ongoing jaundice.
Yellowing of the skin and the whites of the eyes is the hallmark sign. In Crigler-Najjar syndrome, it often begins in the first days of life and does not fade the way routine newborn jaundice usually does.
Some newborns are very sleepy, hard to wake for feeds, feed poorly, or have a high-pitched cry. In daily routines, this might show up as a baby who seems too tired to suck well or is not gaining weight as expected.
When bilirubin levels get very high, babies may become limp or stiff, arch their back, have unusual eye movements, or develop seizures. These signs mean bilirubin may be affecting the brain and need urgent medical care.
If the brain is injured by bilirubin early in life, some children later develop hearing loss, movement problems, or developmental delay. This can lead to slower progress with sitting, walking, balance, or speech.
How people usually first notice Crigler-najjar syndrome?
The first signs of Crigler-Najjar syndrome are usually noticed in the first days of life, when a baby develops intense jaundice that goes beyond the common newborn yellowing and does not improve as expected. Families and doctors may notice yellow skin and eyes, unusual sleepiness, poor feeding, or a baby who seems less alert, all of which can happen because bilirubin, a yellow pigment made when red blood cells break down, builds up to dangerous levels in the blood. How Crigler-Najjar syndrome is first noticed can vary by type, but it is most often recognized during newborn care or early infancy when blood tests show very high bilirubin without the usual signs of liver damage or blocked bile flow.
Types of Crigler-najjar syndrome
Crigler-Najjar syndrome can affect daily life in very different ways depending on which clinical variant someone has. The main types of Crigler-Najjar syndrome are based on how much bilirubin-processing enzyme activity is present, and that difference strongly affects symptom severity. Symptoms don’t always look the same for everyone.
Type 1
This is the more severe form, with little to no working enzyme to clear bilirubin from the body. Jaundice usually begins soon after birth and can become dangerously severe without intensive treatment. People with this type do not respond to phenobarbital, a medicine that can help in the milder form.
Type 2
This form is usually milder because the enzyme still works a little, so bilirubin levels are often lower than in type 1. Many living with Crigler-Najjar syndrome type 2 still develop ongoing jaundice, but severe brain injury from high bilirubin is less common. This type often improves with phenobarbital treatment, which helps doctors distinguish it from type 1.
Can I slow down the onset of symptoms?
No. Crigler-Najjar syndrome is an inherited condition that usually causes very high bilirubin, a yellow waste substance in the blood, from birth or soon after, so lifestyle changes cannot meaningfully delay when symptoms begin. Early medical care can lower bilirubin and help prevent serious harm, and well-established treatment may include light therapy, close blood tests, certain medicines for some types, and sometimes a liver transplant, but this treats the condition after it starts rather than preventing it.
What genetics can tell you about symptoms
Yes. In Crigler-Najjar syndrome, the exact change in the UGT1A1 gene often helps predict how much the body can still clear bilirubin, which can influence which symptoms appear, how severe jaundice is, and how early problems begin. In general, gene changes that leave almost no enzyme activity are linked to the more severe form, with very high bilirubin and symptoms starting soon after birth, while changes that allow some activity are usually linked to a milder form with lower bilirubin levels and fewer serious complications.
Causes and risk factors
Many living with Crigler-Najjar syndrome first notice ongoing jaundice, and the cause is a change in the UGT1A1 gene. These gene changes are usually inherited from both parents, so the risk is highest when both parents are carriers. The gene change keeps the liver from clearing bilirubin well, and this leads to a buildup in the blood. Illness, dehydration, fasting, and some medicines do not cause Crigler-Najjar syndrome, but they can make bilirubin levels rise and symptoms worsen, especially in the milder type 2 form. Knowing your family history is a good first step.
What are the most common causes or risk factors?
Crigler-Najjar syndrome is almost always caused by inherited changes in a liver gene, called UGT1A1, that normally helps the body clear a yellow waste product from old red blood cells. The main risk factor is family history, especially when both parents carry a changed copy of this gene; the chance can also be higher when the parents are related by blood, such as cousins. There are no known lifestyle or environmental causes, although illness, fasting, or some medicines can make jaundice worse in some people living with the milder form.
Environmental and biological risk factors
For Crigler-Najjar syndrome, there are no well-established environmental or non-genetic biological risk factors known to independently increase the chance of the condition occurring. This is because Crigler-Najjar syndrome is typically present from birth rather than triggered by pregnancy exposures, infections, or common maternal health factors. Researchers are still exploring how outside influences interact with our inner biology.
Genetic risk factors
Crigler-Najjar syndrome happens because of inherited changes in the UGT1A1 gene, which helps the liver clear bilirubin, a yellow pigment made when red blood cells break down. Understanding the genetic causes of Crigler-Najjar syndrome can help families make sense of why it appears in some relatives and not others. Carrying a genetic change doesn’t guarantee the condition will appear, because people with one changed copy are usually healthy carriers while the syndrome most often develops when both copies are affected. The exact gene change also helps explain why some people have the more severe type 1 form and others have the milder type 2 form.
UGT1A1 gene: Crigler-Najjar syndrome is caused by harmful changes in the UGT1A1 gene. This gene helps the liver process bilirubin so it can leave the body. When the gene does not work well enough, bilirubin builds up in the blood.
Recessive inheritance: Most people with Crigler-Najjar syndrome inherit one changed UGT1A1 copy from each parent. Doctors call this autosomal recessive inheritance. Parents with just one changed copy are usually healthy carriers.
Carrier parents: If both parents are carriers, each pregnancy has a 1 in 4, or 25%, chance that the child will have Crigler-Najjar syndrome. Each pregnancy also has a 1 in 2, or 50%, chance that the child will be a healthy carrier. These chances stay the same each time, no matter what happened in earlier pregnancies.
Family history: A family history of Crigler-Najjar syndrome, severe newborn jaundice, or a known UGT1A1 change can raise the chance in close relatives. This is especially important for brothers, sisters, and future children in the same family. In some families, genetic counseling can help clarify who may be a carrier.
Variant severity: Different UGT1A1 changes leave different amounts of enzyme activity. Changes that almost completely switch off the enzyme are linked to type 1, while changes that leave some activity are more often linked to type 2. This helps explain why bilirubin levels and illness severity can vary from one family to another.
Shared ancestry: Parents who are related or who come from a smaller population with shared ancestors are more likely to carry the same rare UGT1A1 change. That raises the chance that a child could inherit two changed copies. It does not mean a child will definitely have the condition, but the genetic risk is higher.
Lifestyle risk factors
Crigler-Najjar syndrome is inherited, so lifestyle habits do not cause it. Still, how lifestyle affects Crigler-Najjar syndrome can matter because certain daily habits can raise unconjugated bilirubin levels, worsen jaundice, or increase the chance of complications. The most important factors are regular nutrition, hydration, avoiding liver stressors, and staying consistent with prescribed treatment routines.
Fasting or long gaps between meals can increase bilirubin levels in people with Crigler-Najjar syndrome. Regular eating patterns may help reduce swings in jaundice and lower the risk of bilirubin rising too high.
Dehydration can concentrate bilirubin in the body and may make jaundice more noticeable. Drinking enough fluids, especially during hot weather or illness, can help support more stable day-to-day management.
Alcohol does not cause Crigler-Najjar syndrome, but it can place extra stress on the liver. This may worsen overall liver handling of bilirubin and make symptom control more difficult.
Very strenuous exercise without enough rest, calories, or fluids may contribute to bilirubin increases. Moderate activity is often better tolerated when it is paired with good hydration and regular meals.
Risk prevention
Crigler-Najjar syndrome is inherited, so it usually cannot be prevented from happening in the first place. For people living with Crigler-Najjar syndrome, prevention means lowering the chance of dangerous bilirubin buildup and protecting the brain and liver over time. Different people need different prevention strategies—there’s no single formula.
Early diagnosis and regular care with a liver specialist or metabolic team can help prevent complications of Crigler-Najjar syndrome. This often means tracking bilirubin levels closely and adjusting treatment before levels become dangerous.
For many with Crigler-Najjar syndrome, phototherapy is a key way to lower bilirubin and reduce the risk of brain injury. Using it as prescribed, especially in infancy and childhood, is one of the most important preventive steps.
Illness, poor feeding, vomiting, or not drinking enough can push bilirubin higher in people with Crigler-Najjar syndrome. Quick treatment for dehydration and a plan for sick days can help keep levels safer.
Common infections can stress the body and make bilirubin rise, so routine vaccines and prompt medical care for fever matter. Prevention works best when combined with regular check-ups.
Can you prevent Crigler-najjar syndrome?
Crigler-Najjar syndrome cannot be prevented because it is a rare inherited condition that a baby is born with. If it runs in your family, genetic counseling and carrier testing before or during pregnancy can help you understand the chances of having a child with it, but they do not prevent the condition itself. There is no known diet, medicine, or lifestyle change that can stop it from happening.
Transmission
Crigler-Najjar syndrome is not contagious, so it cannot spread through coughing, kissing, blood, sex, food, or everyday contact. Instead, the genetic transmission of Crigler-Najjar syndrome usually happens before birth, when a baby inherits two changed copies of a gene that helps the body clear bilirubin, one from each parent.
Many parents of a child with Crigler-Najjar syndrome are healthy carriers and may not know they carry the gene change. Rarely, a new gene change can happen for the first time in a family, but Crigler-Najjar syndrome is an inherited condition, not an infectious one.
When to test your genes
Genetic testing is most useful if a newborn has severe, persistent jaundice with very high unconjugated bilirubin, or if there is a family history of Crigler-Najjar syndrome. It can confirm the diagnosis quickly, guide treatment intensity, and help relatives with carrier testing or pregnancy planning.
Diagnosis
Crigler-Najjar syndrome is usually diagnosed when a baby or child has very high jaundice that does not improve in the usual way, or when older testing has shown unusually high bilirubin levels without signs of liver damage. Doctors look at the pattern of symptoms and lab results first, then confirm the diagnosis with more specific testing. Getting a diagnosis is often a turning point toward answers and support.
Blood tests show a very high level of unconjugated bilirubin, the type that has not been processed well by the liver. This is one of the main clues in the diagnosis of Crigler-Najjar syndrome.
Doctors also check other liver blood tests to see whether the liver is otherwise working normally. In Crigler-Najjar syndrome, these results are often normal, which helps separate it from other causes of jaundice.
The diagnosis often starts with persistent jaundice, especially in infancy, without evidence of blocked bile flow or widespread liver disease. In more severe cases, signs of bilirubin affecting the brain may raise urgent concern.
Genetic tests can look for changes in the UGT1A1 gene, which is responsible for this condition. This can confirm the genetic diagnosis of Crigler-Najjar syndrome and may help tell type 1 from type 2.
How is Crigler-najjar syndrome diagnosed?
Doctors usually suspect Crigler-Najjar syndrome when a newborn or young baby has ongoing yellowing of the skin or eyes and blood tests show very high levels of bilirubin, a yellow substance the body normally clears, without the usual signs of liver damage or another clear cause. They often use repeated blood tests and a careful review of symptoms and family history, and they may see whether bilirubin levels improve with a medicine called phenobarbital to help tell which type it is. Genetic testing can then help confirm the diagnosis by looking for a change in the gene that helps the body process bilirubin.
Stages of Crigler-najjar syndrome
Crigler-Najjar syndrome does not have defined progression stages. This is because it is a lifelong inherited condition caused by the body being unable, or only partly able, to clear bilirubin, rather than an illness that typically moves step by step through mild to severe phases. Doctors usually start with a conversation about jaundice and other early symptoms of Crigler-Najjar syndrome, then confirm the diagnosis with blood tests showing high unconjugated bilirubin and, in many cases, genetic testing. Monitoring usually focuses on bilirubin levels over time and checking for signs that treatment needs to be adjusted, especially in babies and children.
Outlook and prognosis
Outlook varies sharply by type: people with Crigler-Najjar syndrome type 1 have a high risk of severe, recurrent unconjugated hyperbilirubinemia leading to kernicterus, neurologic injury, and early death without intensive treatment, while type 2 is usually milder and often compatible with long-term survival. In type 1, daily phototherapy can help during childhood but often becomes less effective with age, so liver transplantation is frequently the only definitive treatment and can greatly improve survival. With early diagnosis and careful management, including avoidance of fasting, illness-related dehydration, and drugs that displace bilirubin from albumin, some complications can be reduced. Type 2 generally responds to phenobarbital and carries a much lower risk of kernicterus, though episodes of worsening jaundice can still occur during stress or illness. Mortality is therefore highest in untreated or poorly controlled type 1, whereas many people with type 2 can have near-normal life expectancy with ongoing monitoring and treatment.
Long-term effects
For many living with Crigler-Najjar syndrome, the long-term picture depends a lot on whether bilirubin levels stay closer to a safer range or remain very high over time. The main concern is injury from ongoing severe jaundice, especially to the brain, which can affect movement, hearing, learning, and development. Long-term effects vary widely, with milder cases often allowing a much more stable outlook than severe forms, and adults may still need ongoing monitoring for lifelong high bilirubin.
The most serious long-term effect of Crigler-Najjar syndrome is bilirubin-related brain damage, sometimes called kernicterus. This can lead to lasting problems with movement, muscle tone, balance, hearing, or learning if bilirubin stays very high, especially early in life.
Some children with severe Crigler-Najjar syndrome may reach milestones later because of early effects on the nervous system. Over time, this can mean ongoing needs with speech, school, coordination, or daily functioning.
Lasting effects on the brain can cause stiffness, involuntary movements, poor balance, or trouble with coordination. In day-to-day life, this may look like an unsteady walk, trouble with fine hand tasks, or fatigue during physical activity.
Severe bilirubin exposure can damage parts of the nervous system involved in hearing. Some people with Crigler-Najjar syndrome may have permanent hearing loss that becomes clearer as language and communication skills develop.
How is it to live with Crigler-najjar syndrome?
Living with Crigler-Najjar syndrome often means daily life is organized around keeping bilirubin levels low, because this rare inherited condition can let bilirubin build up to dangerous levels and, especially in the more severe form, raise the risk of brain injury. For many people, this can mean spending long hours under phototherapy lights, taking regular medicines when prescribed, having frequent blood tests and specialist visits, and planning carefully around illness, fasting, dehydration, or missed treatment. It also affects the people around you: parents, partners, and other caregivers may help manage equipment, watch for warning signs, coordinate medical care, and carry a steady emotional load, even while many families build strong routines that allow school, work, and relationships to continue.
Treatment and drugs
Treatment for Crigler-Najjar syndrome focuses on lowering bilirubin, the yellow pigment that builds up in the blood, to protect the brain and prevent serious complications. In type 1, daily phototherapy, which uses special blue light, is a main treatment from infancy, and some people also need careful nutrition support, close monitoring, and eventually a liver transplant because the body cannot clear bilirubin on its own. In type 2, many living with Crigler-Najjar syndrome improve with a medicine called phenobarbital, which helps the liver process bilirubin better, though the response can vary. Treatment plans often combine several approaches. People with Crigler-Najjar syndrome are also usually advised to avoid dehydration, long fasts, and certain medicines that can raise bilirubin, and regular follow-up helps doctors adjust care over time.
Can you cure Crigler-najjar syndrome?
There is no simple cure for Crigler-Najjar syndrome. Treatment can help lower the buildup of bilirubin, a yellow waste product in the blood, and reduce the risk of serious problems; this may include special light treatment, medicine in some people, and close follow-up. For the most severe form, a liver transplant may offer the closest thing to a long-term cure because it can let the body process bilirubin much more normally.
Non-drug treatment
Daily care for people with Crigler-Najjar syndrome is centered on lowering bilirubin and preventing it from building up to dangerous levels. Managing this condition often means building treatment around light therapy, careful feeding, and close follow-up, especially in babies and young children. Some non-drug options are used every day at home, while others are hospital-based or considered when bilirubin stays hard to control. The best plan depends on the type of Crigler-Najjar syndrome, age, and how high bilirubin levels run.
Special blue-light treatment helps change bilirubin into a form the body can remove more easily. This is the main non-drug treatment for many living with Crigler-Najjar syndrome, and it often needs to be used for long periods each day.
Many families use home phototherapy units so treatment can fit into daily life and sleep routines. This kind of light therapy for Crigler-Najjar syndrome needs careful guidance to make sure the lamp strength, distance, and treatment time are safe and effective.
In newborns and infants, regular feeds and good hydration can help lower the chance of bilirubin rising further. If a baby is sleepy and not feeding well, extra feeding support may be part of treatment.
If bilirubin rises to a dangerous level, doctors may use an exchange transfusion in the hospital to remove bilirubin quickly. This is usually an urgent short-term treatment, most often used in newborns.
Your genes may have an impact on how drugs work for you
In Crigler-Najjar syndrome, the exact genetic change can strongly affect how well certain treatments work, especially medicines meant to help the liver lower bilirubin, the yellow substance that builds up in the body. For example, many people living with the milder form may improve with phenobarbital, while those with the more severe form often get little or no benefit because their liver cannot respond enough. This is one of the clearest real-life examples of how genes can shape medicine response, so doctors often use the genetic type of Crigler-Najjar syndrome to help guide treatment.
Pharmacological treatments
For many living with Crigler-Najjar syndrome, medicines play a limited but important role, and the best-known drug depends on whether someone has type 1 or type 2. Phenobarbital is the main medicine used for Crigler-Najjar syndrome type 2 because it can help the liver clear more bilirubin. Not everyone responds to the same medication in the same way. In type 1, there is no standard drug that reliably controls bilirubin long term, so treatment often depends more on non-drug care.
Phenobarbital is the main drug used for treatment for Crigler-Najjar syndrome type 2. It can lower bilirubin by helping the liver work harder on bilirubin processing, but it usually does not help in type 1. Doctors may monitor for sleepiness, behavior changes, and drug interactions.
In emergencies, especially when bilirubin levels rise to dangerous levels, intravenous albumin may be used short term. It helps hold bilirubin in the bloodstream so it is less likely to reach the brain while urgent treatment is arranged. This is a temporary hospital treatment, not a daily medicine.
For Crigler-Najjar syndrome type 1, no medicine has been shown to reliably keep bilirubin low enough for long-term control. Phenobarbital generally does not work in this form, so people often need intensive light therapy and may later need a liver transplant.
A few medicines, such as tin mesoporphyrin, have been studied in specialist settings to reduce how much bilirubin the body makes. These are not routine treatments for most people with Crigler-Najjar syndrome, and access may be limited. If this comes up, ask your doctor whether it is established care or part of a research approach.
Genetic influences
For families living with Crigler-Najjar syndrome, the genetic link is direct: it happens when a child inherits harmful changes in both copies of the UGT1A1 gene, one from each parent. It’s natural to ask whether family history plays a role. In this condition, parents are usually healthy carriers, but their child’s liver cannot break down bilirubin normally, so jaundice often starts early and bilirubin levels can rise to dangerous levels. Crigler-Najjar syndrome is usually passed down in an autosomal recessive pattern, which means each pregnancy between two carriers has a 1 in 4, or 25%, chance of being affected. Type 1 is more severe because the gene changes leave the enzyme with little to no activity, while type 2 usually leaves some activity and tends to be milder. Genetic testing can help confirm the diagnosis, explain early symptoms of Crigler-Najjar syndrome, and show whether other family members may be carriers.
Is Crigler-najjar syndrome genetic?
Genetics are central to Crigler-Najjar syndrome. It is usually caused by inherited changes in the UGT1A1 gene, and the exact variant often influences severity, which matters for family testing and genetic counseling.
Having a genetic risk is not necessarily a diagnosis
Gene variants are common and are a normal part of human biology. Most of these variants do not directly affect health and are simply part of the natural variation found among people. In many genes, carrying a variant linked to a condition indicates a possible association, not a definite diagnosis, especially when several genes and environmental factors play a role. Still, in some situations, one well-understood variant in a certain gene can be enough to confirm a diagnosis.
Pharmacogenetics—how genetics influence drug effects
For many living with Crigler-Najjar syndrome, treatment depends a great deal on the exact genetic change they were born with. Changes in the UGT1A1 gene affect how well the liver can clear bilirubin, a yellow substance that can build up and harm the brain if levels get too high. Genetic testing can sometimes identify how your body still handles bilirubin, which helps doctors tell apart the more severe type 1 form from the milder type 2 form. That matters because people with type 2 often improve with phenobarbital, while people with type 1 usually do not, since they have little to no working enzyme. For many with severe Crigler-Najjar syndrome, this can mean many hours of phototherapy under special blue light each day and, over time, possibly a liver transplant as the only long-term treatment. For families trying to understand how genetics affect treatment for Crigler-Najjar syndrome, the key point is that the gene result does more than confirm the diagnosis; it helps guide which treatments are likely to help and how closely bilirubin needs to be watched.
Interactions with other conditions
People with Crigler-Najjar syndrome may find that jaundice becomes more noticeable when another illness puts extra stress on the body, such as an infection, a stomach bug, or a condition that causes dehydration. Blood disorders that break red blood cells down faster, such as hemolytic anemia, can also raise bilirubin levels and make Crigler-Najjar syndrome harder to manage. If someone also has liver inflammation or another liver condition, the body may have even more trouble clearing bilirubin, which can increase the risk of symptoms becoming more severe. In day-to-day life, this can mean yellowing of the skin deepens during an illness, or a baby who was stable suddenly seems sleepier and feeds less well. Interactions can look very different from person to person. Because of this, doctors usually watch closely for any new illness in people living with Crigler-Najjar syndrome and may adjust treatment plans quickly to help prevent dangerous bilirubin buildup.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
What other conditions can cause similar symptoms to Crigler-najjar syndrome?
Other causes of ongoing yellowing of the skin and eyes include common newborn jaundice, jaundice linked to breast milk or poor feeding, and problems that make red blood cells break down too quickly, such as blood type mismatch or some inherited blood conditions. Doctors may also consider a milder inherited condition called Gilbert syndrome, as well as liver or bile flow problems that can also raise the yellow pigment in the blood. The age when symptoms start, how severe the jaundice is, and blood tests help tell these apart from Crigler-Najjar syndrome.
History
For families living with Crigler-Najjar syndrome, the history of the condition helps explain why diagnosis and treatment have changed so much over time. Long before modern lab testing, babies with severe, long-lasting jaundice were sometimes recognized as being different from those with the more common newborn jaundice that fades on its own. Some infants stayed deeply yellow, became unusually sleepy, or developed serious nerve-related problems, but doctors did not yet have a clear way to group these cases together.
In recent decades, awareness has grown, but the modern medical description of Crigler-Najjar syndrome began in the 20th century, when physicians reported children with very high bilirubin levels that could not be explained by the usual causes of liver disease or blood breakdown. Over time, doctors realized this was not simply a more stubborn form of typical jaundice. It was a distinct rare disorder, and later reports showed that Crigler-Najjar syndrome could appear in different forms, with some people having more severe illness than others.
As medical science improved, blood testing made it easier to measure bilirubin accurately and follow how the condition behaved over time. This helped doctors understand the early symptoms of Crigler-Najjar syndrome and the risks linked to bilirubin building up in the body, especially in infancy. Researchers later identified a genetic cause, which confirmed that the problem begins with the body’s difficulty processing bilirubin rather than with an infection or a blocked bile duct.
The history of Crigler-Najjar syndrome also reflects progress in treatment. Before effective light therapy and, in some cases, liver transplantation, options were limited and outcomes were often poor in the most severe form. Today, many living with Crigler-Najjar syndrome benefit from earlier diagnosis, closer monitoring, and better supportive care. While it remains a very rare condition, its history shows how careful observation, improved testing, and long-term follow-up can turn a once poorly understood illness into one that is recognized much earlier and managed more effectively.